C12Y 204/99018
Dolichyl-diphosphooligosaccharide—protein glycotransferase
Official title: Dolichyl-diphosphooligosaccharide—protein glycotransferase (2.4.99.18)
C12Y204/99018 (Dolichyl-diphosphooligosaccharide—protein glycotransferase) appears on 8 US grants and 17 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 17
- Assignees
- 18
- Inventors
- 63
- Latest grant
- 25 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 3 |
| 2018 | 0 | 0 |
| 2019 | 3 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 3 |
| 2022 | 2 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 3 |
By publication year.
Recent patents
- Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereof25 Feb 2025US 12,233,121 B2GlaxoSmith Kline Biologicals s.a., a corporation
- Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof8 Nov 2022US 11,491,220 B2GlaxoSmithKline Biologal S.A.
- Modified host cells and hybrid oligosaccharides for use in bioconjugate production29 Mar 2022US 11,285,200 B2Glaxosmithkline Biologicals SA
- Production of glycoproteins with mammalian-like N-glycans in filamentous fungi24 Dec 2019US 10,513,724 B2Glykos Finland Oy
- Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells2 Jul 2019US 10,337,012 B23-D Matrix, Ltd.
- Cell-free enzymatic method for preparation of n-glycans25 Dec 2025US 2025/0388948 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Genetically-modified filamentous fungi for production of exogenous proteins having reduced or no n-linked glycosylation13 Nov 2025US 2025/0346853 A1Dyadic International (USA), Inc.
- Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof10 Jul 2025US 2025/0222093 A1Glaxosmithkline Biologicals SA
- Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof22 Jun 2023US 2023/0190926 A1Glaxosmithkline Biologicals SA
- Recombinant organisms and methods for producing glycomolecules with high glycan occupancy24 Jun 2021US 2021/0189002 A1Conagen Inc.
Most cited
By later US patents
- Glycosylated protein expression in prokaryotes14US 8,999,668 B2Cornell Research Foundation, Inc. · 2015
- Modified host cells and hybrid oligosaccharides for use in bioconjugate production3US 10,307,474 B2Glaxosmithkline Biologicals SA · 2019
- Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells2US 10,337,012 B23-D Matrix, Ltd. · 2019
- Production of glycoproteins with mammalian-like N-glycans in filamentous fungi1US 10,513,724 B2Glykos Finland Oy · 2019
- Glycosylated protein expression in prokaryotes1US 9,512,434 B2Cornell Research Foundation, Inc. · 2016